Distinct Serotypes of Streptococcal M Proteins Mediate Fibrinogen-Dependent Platelet Activation and Proinflammatory

Frida Palm1, Sounak Chowdhury1, Sara Wettemark1

  • 1Division of Infection Medicine, Department of Clinical Sciences, Lund Universitygrid.4514.4, Lund, Sweden.

Infection and Immunity
|December 13, 2021
PubMed

Insights

Certain Streptococcus pyogenes M protein serotypes (M1, M3, M5) activate platelets and immune cells by binding fibrinogen, contributing to sepsis. Other serotypes lack this pro-inflammatory effect.

Area of Science:

  • Immunology
  • Microbiology
  • Hematology

Background:

  • Sepsis, a life-threatening infection complication, involves inflammation and hemostasis disruption.
  • Platelets regulate hemostasis and inflammation; Streptococcus pyogenes M protein serotypes vary in invasive potential.
  • M1 protein from S. pyogenes activates platelets, neutrophils, and monocytes.

Purpose of the Study:

  • To investigate the pro-inflammatory effects of M protein serotypes (M3, M5, M28, M49, M89) from Streptococcus pyogenes.
  • To determine the role of fibrinogen and IgG in M protein-mediated immune cell activation.

Main Methods:

  • Multiparameter flow cytometry
  • Enzyme-linked immunosorbent assay (ELISA)
  • Platelet aggregometry
  • Quantitative mass spectrometry

Main Results:

  • M1, M3, and M5 S. pyogenes M proteins bind fibrinogen and activate platelets.
  • Fibrinogen and IgG mediate platelet activation, aggregation, and granule release.
  • M1, M3, and M5 proteins induce neutrophil and monocyte activation (CD11b upregulation).
  • M28, M49, and M89 proteins did not activate platelets or leukocytes.

Conclusions:

  • Specific S. pyogenes M protein serotypes (M1, M3, M5) possess potent immunomodulatory functions.
  • Fibrinogen binding and subsequent platelet activation are key mechanisms in M protein-induced inflammation.
  • Findings highlight novel pathways in streptococcal infections and sepsis pathogenesis.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.7K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.1K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.9K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
734
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.0K